Cutler Group’s Proshares UltraPro NASDAQ Biotechnology UBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,200
| Closed | -$3K | – | 5012 |
|
|
2019
Q4 | $3K | Buy |
+1,200
| New | +$31.9K | ﹤0.01% | 3376 |
|
|
2019
Q3 | – | Sell |
-1,100
| Closed | -$1K | – | 5009 |
|
|
2019
Q2 | $1K | Sell |
1,100
-2,900
| -73% | -$71.6K | ﹤0.01% | 4112 |
|
|
2019
Q1 | $2K | Buy |
+4,000
| New | +$114K | ﹤0.01% | 3548 |
|
|
2018
Q4 | – | Sell |
-600
| Closed | -$2K | – | 4936 |
|
|
2018
Q3 | $2K | Sell |
600
-1,400
| -70% | -$56.5K | ﹤0.01% | 3655 |
|
|
2018
Q2 | $3K | Buy |
+2,000
| New | +$62.3K | ﹤0.01% | 3487 |
|
|
2018
Q1 | – | Sell |
-900
| Closed | -$1K | – | 5646 |
|
|
2017
Q4 | $1K | Sell |
900
-2,600
| -74% | -$88.8K | ﹤0.01% | 4706 |
|
|
2017
Q3 | $1K | Sell |
3,500
-2,800
| -44% | -$97.5K | ﹤0.01% | 5674 |
|
|
2017
Q2 | $18K | Buy |
6,300
+5,100
| +425% | +$143K | ﹤0.01% | 3557 |
|
|
2017
Q1 | $2K | Sell |
1,200
-11,400
| -90% | -$300K | ﹤0.01% | 5658 |
|
|
2016
Q4 | $39K | Buy |
12,600
+7,900
| +168% | +$187K | ﹤0.01% | 2807 |
|
|
2016
Q3 | $12K | Sell |
4,700
-2,400
| -34% | -$68.3K | ﹤0.01% | 4055 |
|
|
2016
Q2 | $4K | Buy |
7,100
+1,100
| +18% | +$27.9K | ﹤0.01% | 5241 |
|
|
2016
Q1 | $7K | Buy |
6,000
+4,300
| +253% | +$119K | ﹤0.01% | 4549 |
|
|
2015
Q4 | $7K | Buy |
+1,700
| New | +$90K | ﹤0.01% | 4620 |
|
Other funds holding UBIO
Cutler Group's UBIO Position: Q1 2020 in Review
Cutler Group sold out of Proshares UltraPro NASDAQ Biotechnology (UBIO) in Q1 2020, closing a stake of 1,521 shares — an estimated $49K sold.
Cutler Group first reported a position in UBIO in Q4 2015 and held it in 10 quarters. The position peaked at $171K in Q4 2015. 1 fund tracked by Wall St. Rank holds UBIO as of Q1 2020.
- Cutler Group reported no remaining Proshares UltraPro NASDAQ Biotechnology position as of Q1 2020 after selling out during the quarter.
- Cutler Group sold 1,521 Proshares UltraPro NASDAQ Biotechnology shares in Q1 2020, an estimated $49K.
- Cutler Group first reported a position in Proshares UltraPro NASDAQ Biotechnology in Q4 2015 and held it in 10 quarters.
- Cutler Group's Proshares UltraPro NASDAQ Biotechnology position peaked at $171K in Q4 2015.
- 1 fund tracked by Wall St. Rank held Proshares UltraPro NASDAQ Biotechnology as of Q1 2020.
Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.